small molecule

FERAHEME

FERUMOXYTOL

Loss of exclusivityloss of exclusivity
CompanyAZURITY PHARMACEUTICALS SWITZERLAND GMBH

Drug detail

Brand nameFERAHEME
Active ingredientFERUMOXYTOL
StrengthEQ 510MG IRON/17ML (EQ 30MG IRON/ML)
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalJune 2009
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

FERAHEME patent cliff — loss of exclusivity — | CliffBio